Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ondansetron hydrochloride dihydrate, quantity: 4.986 mg (equivalent: ondansetron, qty 4 mg) - tablet, film coated - excipient ingredients: pregelatinised maize starch; triacetin; titanium dioxide; microcrystalline cellulose; hypromellose; lactose; magnesium stearate - ondansetron is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

orion pharma (aus) pty limited - selegiline hydrochloride, quantity: 5 mg - tablet, uncoated - excipient ingredients: magnesium stearate; povidone; maize starch; microcrystalline cellulose; mannitol - as an adjunct in the management of late stage parkinson's disease in patients being treated with levodopa and/or a peripheral decarboxylase inhibitor, who exhibit deterioration in the quality of their response to the therapy. indications as approved 22 january 1999 - eldepryl is indicated for the treatment of patients with parkinson's disease. it can be used as monotherapy in the early phases of the disease and as adjunctive therapy with levodopa (with/without a peripheral decarboxylase inhibitor) as an adjunct in the management of late stage parkinson's disease in patients being treated with levodopa and/or a peripheral decarboxylase inhibitor, who exhibit deterioration in the quality of their response to the therapy. indications as approved 22 january 1999 - eldepryl is indicated for the treatment of patients with parkinson's disease. it can be used as monotherapy in the early phases of the disease and as adjunctive therapy with levodopa (with/without a peripheral decarboxylase inhibitor)

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

haleon australia pty ltd - paracetamol, quantity: 500 mg; pseudoephedrine hydrochloride, quantity: 30 mg - tablet, uncoated - excipient ingredients: stearic acid; povidone; purified talc; sodium benzoate; pregelatinised maize starch; maize starch - for the temporary relief of sinus congestion and pain, nasal congestion and runny nose.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - terbinafine hydrochloride, quantity: 281.31 mg (equivalent: terbinafine, qty 250 mg) - tablet, uncoated - excipient ingredients: magnesium stearate; sodium starch glycollate type a; purified talc; microcrystalline cellulose; colloidal anhydrous silica; hypromellose - treatment in adults of ringworm (tinea corporis, tinea cruris and tinea pedis) due to infection caused by dermatophytes such as trichophyton (e.g. t. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum), microsporum canis and epidermophyton floccosum, where oral therapy is considered appropriate owing to the site, severity or extent of the infection, and the infection is not responsive to topical therapy. onychomycosis in adults (fungal infection of the nail) caused by dermatophyte fungi.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - methyldopa sesquihydrate, quantity: 283 mg (equivalent: methyldopa, qty 250 mg) - tablet, film coated - excipient ingredients: ethylcellulose; disodium edetate; magnesium stearate; guar gum; sodium starch glycollate; colloidal anhydrous silica; citric acid; titanium dioxide; hypromellose; sunset yellow fcf; quinoline yellow; macrogol 400 - indications as at 7 may 1996: hypertension (mild, moderate to severe)

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

bristol-myers squibb australia pty ltd - cobicistat, quantity: 150 mg; atazanavir, quantity: 300 mg - tablet, film coated - excipient ingredients: stearic acid; croscarmellose sodium; hyprolose; crospovidone; magnesium stearate; sodium starch glycollate; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide red - evotaz is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

bristol-myers squibb australia pty ltd - deucravacitinib, quantity: 6 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; hypromellose acetate succinate; microcrystalline cellulose; silicon dioxide; lactose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - sotyktu is indicated for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - omeprazole, quantity: 20 mg - tablet, enteric coated - excipient ingredients: purified talc; hypromellose; iron oxide red; carnauba wax; sodium stearylfumarate; iron oxide yellow; titanium dioxide; sodium stearate; sodium lauryl sulfate; hypromellose acetate succinate; sodium starch glycollate; propylene glycol; lactose monohydrate; triethyl citrate; monoethanolamine - gastroesophageal reflux disease (gord). symptomatic gord: the relief of heartburn and other symptoms associated with gord. . erosive oesophagitis: the treatment and prevention of relapse. . peptic ulcers: the treatment of duodenal and gastric ulcer. . combination therapy for the treatment of peptic ulcer disease associated with h. pylori infection. . the treatment of gastric and duodenal ulcers and erosions associated with non-steroidal anti-inflammatory drugs. . the prevention of gastric and duodenal ulcers and erosions associated with non-steroidal anti-inflammatory drugs in patients assessed as being at high risk of gastroduodenal ulcer or complications of gastroduodenal ulcer. . long-term prevention of relapse in gastric and duodenal ulceration, in patients proven to be h. pylori negative, or in whom eradication is inappropriate, e.g. the elderly or ineffective. . zollinger-ellison syndrome: the treatment of zollinger-ellison syndrome

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - loratadine, quantity: 10 mg - tablet, film coated - excipient ingredients: carnauba wax; lactose monohydrate; magnesium stearate; microcrystalline cellulose; pregelatinised maize starch; maize starch; purified talc; silicon dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - in adults and children 12 years and older: treatment of seasonal and perennial allergic rhinitis; relief of symptoms and signs of chronic urticaria.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydrocortisone, quantity: 20 mg - tablet, uncoated - excipient ingredients: povidone; magnesium stearate; macrogol 8000; lactose monohydrate; maize starch - indications as at 6 may 1992: hydrocortisone is indicated for replacement therapy in addison's disease or chronic adrenocortical insufficiency secondary to hypopituitarism.